Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
Vitamin D supplementation
Respiratory Distress Syndrome
0303 health sciences
Immune cytotoxic response
SARS-CoV-2
Immunity
COVID-19
Vitamins
Article
COVID-19 Drug Treatment
3. Good health
03 medical and health sciences
Dietary Supplements
Humans
Single-Blind Method
Prospective Studies
Vitamin D
Cholecalciferol
DOI:
10.1016/j.biopha.2022.112965
Publication Date:
2022-04-14T07:13:33Z
AUTHORS (51)
ABSTRACT
Main cause of severe illness and death in COVID-19 patients appears to be an excessive but ineffectual inflammatory immune response that may acute respiratory distress syndrome (ARDS). Vitamin D favour anti-inflammatory environment improve cytotoxic against some infectious diseases. A multicenter, single-blind, prospective, randomized clinical trial was approved with pneumonia levels 25-hydroxyvitamin (25(OH)D) 14.8 ng/ml (SD: 6.18) test antiviral efficacy, tolerance safety 10,000 IU/day cholecalciferol (vitamin
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (63)
CITATIONS (32)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....